RxDoctor Payments Data

Darrell Tuck, NP

Nurse Practitioner · Gastonia, NCNPI 1073243572

Payments from drug & device makers

$219in general payments, 2019–2025

Across 11 payments — averaging $19.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Dexcom, Inc.$42
  • Nevro Corp.$40
  • Novo Nordisk$25
  • Amgen$24
  • Johnson & Johnson$22
  • Exact Sciences$22
  • plus $45 from 3 others

What the payments were for

  • Food & beverage$219100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$219 in reported general payments places this provider in the 55th percentile of 4,393 nurse practitioner providers in North Carolina.

See all nurse practitioner providers in North Carolina

Medicare billing

Part B allowed, 2024
$10,805
Medicare patients
85
Services billed
187

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin87$125,999
MounjaroTirzepatide52$94,692
EliquisApixaban50$70,839
TrulicityDulaglutide31$67,253
OzempicSemaglutide34$60,054
Trelegy ElliptaFluticasone/Umeclidin/Vilanter30$42,629
Tresiba Flextouch U-100Insulin Degludec74$40,983
RybelsusSemaglutide16$33,882
EntrestoSacubitril/Valsartan13$26,237
XareltoRivaroxaban17$24,876
FarxigaDapagliflozin Propanediol15$20,352
Breztri AerosphereBudesonide/Glycopyr/Formoterol11$18,662
SymbicortBudesonide/Formoterol Fumarate35$15,753
Breo ElliptaFluticasone/Vilanterol11$12,061
MyrbetriqMirabegron17$11,557

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$14$161,94583 claims
Novo NordiskOzempic, Rybelsus$25$93,93650 claims
Johnson & JohnsonXarelto$22$24,87617 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 4,393 nurse practitioner providers in North Carolina.

Other nurse practitioner in Gastonia

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →